Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-15
2009-08-04
Shiao, Rei-tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S448000, C514S444000, C549S068000, C549S070000, C549S059000
Reexamination Certificate
active
07569600
ABSTRACT:
Compounds represented by formula I:or pharmaceutically acceptable salts and solvates thereof, wherein R1, X, Y, Y1, and Z are as defined herein, are useful for treating flaviviridae viral infections.
REFERENCES:
patent: 3076817 (1963-02-01), Fiesselmann et al.
patent: 3470151 (1969-09-01), Doyel et al.
patent: 4180662 (1979-12-01), Pfister et al.
patent: 4877793 (1989-10-01), Davies
patent: 5783705 (1998-07-01), Blok et al.
patent: 6187799 (2001-02-01), Wood et al.
patent: 6248767 (2001-06-01), Blok et al.
patent: 6294276 (2001-09-01), Ogino
patent: 6380214 (2002-04-01), Gant et al.
patent: 6414013 (2002-07-01), Fancelli et al.
patent: 6432994 (2002-08-01), Wu et al.
patent: 6448290 (2002-09-01), Ohuchida et al.
patent: 6458805 (2002-10-01), Blok et al.
patent: 6620767 (2003-09-01), Ducray et al.
patent: 6660728 (2003-12-01), Scheunemann et al.
patent: 6660732 (2003-12-01), Betageri et al.
patent: 6683103 (2004-01-01), Wu et al.
patent: 6734207 (2004-05-01), Uckun et al.
patent: 6747057 (2004-06-01), Ruzafa et al.
patent: 6835745 (2004-12-01), Coghlan et al.
patent: 6858223 (2005-02-01), Hafner
patent: 6881741 (2005-04-01), Kong et al.
patent: 6887877 (2005-05-01), Chan Chun Kong et al.
patent: 6892279 (2005-05-01), Mekheil
patent: 6960594 (2005-11-01), Labrecque et al.
patent: 6982279 (2006-01-01), Peukert et al.
patent: 6984737 (2006-01-01), Hartmann et al.
patent: 7019027 (2006-03-01), Linden et al.
patent: 7084170 (2006-08-01), Grossman et al.
patent: 7084171 (2006-08-01), Grainger et al.
patent: 7098240 (2006-08-01), Griffiths et al.
patent: 7098241 (2006-08-01), Grossman et al.
patent: 7138530 (2006-11-01), Subasinghe et al.
patent: 7166639 (2007-01-01), Wan et al.
patent: 7179836 (2007-02-01), Adams et al.
patent: 2005/0009804 (2005-01-01), King et al.
patent: 2007/0099929 (2007-05-01), Thede et al.
patent: 2 496 680 (1998-11-01), None
patent: 2 385 972 (2001-04-01), None
patent: 1 055 007 (1959-04-01), None
patent: 199 03 398 (2000-08-01), None
patent: 199 20 247 (2000-11-01), None
patent: 63-141984 (1988-06-01), None
patent: 7-48360 (1995-02-01), None
patent: 2001-010957 (2001-01-01), None
patent: 2004-513163 (2004-04-01), None
patent: WO 98/49162 (1998-11-01), None
patent: WO 98/52558 (1998-11-01), None
patent: WO 98/52559 (1998-11-01), None
patent: WO 00/20358 (2000-04-01), None
patent: WO 00/66094 (2000-11-01), None
patent: WO 02/28353 (2002-04-01), None
patent: WO 02/38542 (2002-05-01), None
patent: WO 2004/052879 (2004-06-01), None
patent: WO 2005/063734 (2005-07-01), None
patent: WO 2006/072347 (2006-07-01), None
patent: WO 2006/072348 (2006-07-01), None
Written Opinion and International Search Report for International Application No. PCT/CA2006/000786.
David McKinnon et al., “The Conversions of Izothiazolium Salts into Thiophenecarboxylic Ester Derivatives”,Can. J. Chem., 1984, vol. 62, pp. 1580-1584.
Pilar Goya et al., Synthesis of 4-Oxo- 3,4-dihydro-1H-thieno [3,4-c] and thieno [3,2-c][1,2,6]thiadiazine 2,2-Dioxides,Synthesis, Apr. 1989, pp. 280-282.
Bo Sung Kim et al., “Reactions of ThiaroylketeneS,N-Acetals with 1,3-Dicarbonyl Compounds in the Presence of Mercury (II) Acetate: A General Route to 2-Acyl-and 2 Aroyl-3-(alkylamino)-5-arylthiopenes and 2-(Ethoxycarbonyl)-3-(methylamino)-5-arylthiopenes”,J. Org. Chem., 1998, vol. 63, pp. 6086-6087.
Bo Sung Kim et al., “A Facile and Convenient Synthesis of 3-Alkylamino-5-arylthiopenes with a Variety of Substituents at C-2 and Studies of Reaction Mechanisms”,J. Org. Chem, 2000, vol. 65, pp. 3690-3699.
Ya. L. Gol'dfarb et al., “Action of Alkali Metals in Liquid Ammonia on Substituted Thiophenes. Communication 9. Preparation of 5-Mercapto-4-Ketoalkanoic Acids by Reductive Cleavage of 4-Acetylamino- and 4-Nitrothiphene-2-Carboxylic Acids”,Izv. Akad. NaukSSSR,Ser. Khim., 1984, vol. 10, pp. 2136-2139.
J. R. Desai et al.; J. Ind. Chem. Soc., vol. 74, 1997, p. 160, “Thieno[3,2-d]pyrimidines— Part-I: Preparation and Antimicrobial Activity of 3-N-Substituted-tioureido-2-methyl-6-phenylthieno[3,2-d]pyrimidin-4(3H)-ones”, ISR ref. XP002220249.
E. Marchand, G. Morel, Bull. Soc. Chim. FR. vol. 133, No. 9, 1996, p. 903-912, “Alpha-Thioxothioamides Reactions de cycloaddition [4+2] avec l'acetylenedicarboxylate de dimethyle et le propiolate de methyle”, ISR ref. XP002220251.
W. Kantlehner et al., J. Prakt. Chem., vol. 338, 1996, p. 403-413; “Orthoamide, IL. Umsetzungen von Orthoamid-Derivaten mit Schwefel und Selen, Synthesen von 1,3-Thiazol- und 1,3-Selenazolderivaten” ISR ref. XP002220245.
S. Vega et al., Eur. J. Med. Chem. vol. 23, No. 4, 1988, p. 329-334; “Thiophene Isosteres: Synthesis and Pharmacological Study of 3-(azol-l-yl)thieno isothiazole-1, 1-dioxides” ISR ref. XP002220246.
R.A. Smith et al., Bioorg. Med. Chem. Lett. vol. 11, No. 20, 2001, p. 2775-2778; “Discovery of Heterocyclic Ureas as a New Class of Raf Kinase Inhibitors: Identification of a Second Generation Lead by a Combinatorial Chemistry Approach”, ISR ref. XP001118699.
A.M. Redman et al., Bioorg. Med. Chem. Lett., vol. 11, 2001, p. 9-12; “P38 Kinase Inhibitors for the Treatment of Arthritis and Osteoporosis: Thienyl, Furyl, and Pyrrolyl Ureas”, ISR ref. XP004225311.
D.J. Lee et al., Chemical Abstracts Service, Columbus, OH, U.S., “Novel Synthesis of 5,6-Dihydro-4H-thieno[3,2-b]pyrrol-5-ones via the Rhodium(II)-Mediated Wolff Rearrangement of 3-(2-Thienyl)-3-oxo-2-diazopropanoates”; Database accession No. 2002:151873, ISR ref. XP002220252.
M. Sugiyama et al., Chem. Pharm. Bull. vol. 37, No. 8, 1989, p. 2091-2102; “Condensed Thienopyrimidines. I. Synthesis and Gastric Antisecretory Activity of 2,3-Dihydro-5H-oxazolothienopyrimidin-5-one Derivatives”, ISR ref. XP001118351.
J.C. Lancelot et al., J. Heterocycl. Chem. vol. 33, No. 2, 1996, p. 427-430; “A Facile Synthesis of New Beta-Lactams”, ISR ref. XP002220247.
J.R. Desai et al., J. Inst. Chemists (INDIA) vol. 67, 1995, p. 136-137, “Thieno[3,2-d]pyrimidines—Part—II: Preparation and Antimicrobial Activity of 2-methyl-3-N-Arylsulphonamido-6-Phenylthieno[3,2-d]Pyrimidin-4(3H)-ones”, ISR ref. XP002220249.
Goldfarb et al., Zhurnal Obshchei Khimi, vol. 29, 1959, pp. 3636-3644.
Patent Abstract for Japanese Patent Publication No. 2001-010957, Jan. 16, 2001.
International Search Report for Application No. PCT/CA02/00876 mailed Nov. 26, 2002.
International Search Report for International Application No. PCT/CA2007/002064, 2007.
CA 139:365176, Roberts et al., “Preparation of Nucleoside Derivatives for Treating Hepatitis C Virus Infection.”, 2003.
CA 142:253391, Hadziyannis et al., “Emerging Treatments in Chronic Hepatitis B.”, 2004.
CA 129: 285628, Sostegni et al., “Sequential Versus Concomitant Administration of Ribavirin and Interferon alpha-3 in Patients whit Chronic Hepatitis C not Responding to Interferon Alone.” 1998.
CA 2007:977620, Vicari et al., “Safety, Pharmacokietics and Immune Effects in Normal Volunteers of CPG 10101(ACTILON).”, 2007.
Office Action issued Mar. 29, 2006 in U.S. App. No. 10/730,272.
Office Action issued Aug. 24, 2006 in U.S. Appl. No. 10/730,272.
Office Action issued Mar. 14, 2007 in U.S. Appl. No. 10/730,272.
Notice of Allowance issued Sep. 28, 2007 in U.S. Appl. No. 10/730,272.
Office Action issued May 2, 2008 in U.S. Appl. No. 11/433,749.
Office Action issued Sep. 18, 2007 in U.S. Appl. No. 11/042,442.
Notice of Allowance issued Mar. 17, 2008 in U.S. Appl. No. 11/042,442.
U.S. Appl. No. 11/442,442.
U.S. Appl. No. 11/984,330.
U.S. Appl. No. 12/068,237.
Chan, L. et al., Scientific presentation: 16th ICAR—Savannah, Apr. 2003, Shire BioChem Inc.
Chan, Laval et al., Bioorganic & Medicinal Chemistry Letters, 14 (2004), 793-796.
Chan, Laval et al., Bioorganic & Medicinal Chemistry Letters, 14 (2004), 797-800.
Chan, Laval et al., J. Med. Chem 2003, 46, 1283-1285.
Liu et al., Liquid Crystals, 2001, vol. 28, No.
Chan Chun Kong Laval
Das Sanjoy Kumar
Denis Réal
Motorina Irina
Poisson Carl
Millen White Zelano & Branigan P.C.
Shiao Rei-tsang
ViroChem Pharma Inc.
LandOfFree
Compounds and methods for the treatment of prevention of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods for the treatment of prevention of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for the treatment of prevention of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4093715